August 10, 2017 / 8:40 PM / a month ago

BRIEF-TherapeuticsMD provides TX-004HR regulatory update

Aug 10 (Reuters) - TherapeuticsMD Inc:

* TherapeuticsMD provides TX-004HR regulatory update

* TherapeuticsMD Inc - announced a regulatory update regarding new drug application (NDA) for TX-004HR

* TherapeuticsMD Inc - company has received a formal general advice letter from FDA stating that an initial review of this information has been completed

* TherapeuticsMD Inc - FDA requesting that company submit additional endometrial safety information to NDA for TX-004HR on or before September 18, 2017

* TherapeuticsMD Inc - company currently plans to re-submit NDA for TX-004HR shortly after November 3, 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below